Nagi Ayad

Professor Georgetown University

Dr. Nagi G. Ayad is a Professor in the Department of Oncology and Associate Director of Translational Research at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center. Dr. Ayad received his undergraduate degree from Rutgers University in 1992, worked for Merck & Co., Inc. as a biochemist and then pursued graduate studies with Dr. Ira Mellman at Yale University. Dr. Ayad completed his Ph.D. in Cell Biology in 1998 and moved to Harvard Medical School in 1999 to perform a postdoctoral fellowship with Dr. Marc Kirschner. He has held faculty positions at the Scripps Research Institute and the University of Miami before joining Georgetwon University. He has published extensively on the cell cycle and brain cancer and has developed novel small molecules and computational programs for treating medulloblastoma and glioblastoma.

Seminars

Tuesday 8th September 2026
Expanding the Druggable Landscape: Targeting Signalling, Cytoskeletal & Chromatin Pathways to Unlock Next-Generation RAS Combination Strategies
11:30 am
  • Identifying novel druggable vulnerabilities across signalling, cytoskeletal, and chromatin networks to open new therapeutic opportunities beyond conventional targets
  • Targeting protein-protein interactions and defining optimal developmental treatment windows to maximize inhibitor impact while improving translational success
  • Leveraging RAC and RAS pathway biology alongside a predictive combination platform to design rational therapies, validated through pioneering brain cancer research and published studies
Nagi